Provided by Tiger Trade Technology Pte. Ltd.

Sanofi SA

46.78
+0.16000.34%
Post-market: 46.780.00000.00%17:41 EDT
Volume:3.68M
Turnover:174.09M
Market Cap:112.55B
PE:12.45
High:47.83
Open:47.50
Low:46.76
Close:46.62
52wk High:56.00
52wk Low:43.32
Shares:2.41B
Float Shares:2.20B
Volume Ratio:1.29
T/O Rate:0.17%
Dividend:2.27
Dividend Rate:4.86%
EPS(TTM):3.76
EPS(LYR):3.76
ROE:6.66%
ROA:4.65%
PB:1.37
PE(LYR):12.45

Loading ...

Bristol Myers Squibb Stock Is Too Cheap to Ignore -- Barrons.com

Dow Jones
·
Nov 22, 2025

This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy. -- Barrons.com

Dow Jones
·
Nov 20, 2025

Oppenheimer pharmaceuticals analysts hold analyst/industry conference call

TIPRANKS
·
Nov 20, 2025

Press Release: Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy

Dow Jones
·
Nov 18, 2025

How to Get Workers Back to the Office? Fresh Air, Bees, and Farmers Markets. -- Barrons.com

Dow Jones
·
Nov 15, 2025

Sanofi facility in France cited for quality control issues by ANSM

TIPRANKS
·
Nov 14, 2025

Sanofi Says European Union Approves Drug to Delay Onset of Stage 3 Type 1 Diabetes

MT Newswires Live
·
Nov 14, 2025

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday

MT Newswires Live
·
Oct 28, 2025

Sanofi Coverage Assumed by Jefferies at Buy

Dow Jones
·
Oct 27, 2025

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
Oct 25, 2025

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading

MT Newswires Live
·
Oct 24, 2025

Stock Track | Sanofi Soars 5.05% Pre-market on Strong Q3 Results, Driven by Record Dupixent Sales

Stock Track
·
Oct 24, 2025

Sanofi Results Reflect Improved Efficiency, Should Ease Margin Worries -- Market Talk

Dow Jones
·
Oct 24, 2025

Sanofi's Dupixent Drives Growth, But Lantus Gains Set to Fade -- Market Talk

Dow Jones
·
Oct 24, 2025

Stock Track | Sanofi Soars 5.03% as Q3 Profits Beat Expectations, Driven by Record Dupixent Sales

Stock Track
·
Oct 24, 2025

Sanofi's Dupixent Sales Exceeds €4 Billion for the First Time; Q3 Profits Surpass Expectations

Stock News
·
Oct 24, 2025

Review & Preview: Inflation Data, Baby! -- Barrons.com

Dow Jones
·
Oct 24, 2025

Sanofi, Medidata expand partnership

TIPRANKS
·
Oct 23, 2025

Sanofi Expands Partnership With Medidata to Deploy Artificial Intelligence in Life Sciences Research

MT Newswires Live
·
Oct 23, 2025

Sanofi Drug Shows Superior Efficacy In Genetic Disease Compared To Current Standard Therapy

Benzinga_recent_news
·
Oct 23, 2025